Chicago Community Development Grant - Medium

The Start.Pivot.Grow. Micro Grant provides $2,500 in non-dilutive funding to small businesses for essential expenses like rent, inventory, or marketing. Open to U.S.-based, for-profit companies with at least two years of operation, eligible applicants must generate $50,000+ annually and have no more than two employees, including the owner. Winners will also receive a digital business growth planner and a Prep My Loan Planner to support their development. Grants are awarded quarterly, with applications accepted on a rolling basis.

The Main Street Revitalization Program is designed to encourage economic vitality and growth of a business district within Long Island. This program offers financial incentive awards for customers undertaking renovation or expansion projects to startup or grow their business. Applicants may qualify for maximum award ranging from $5000 to $100,000 based on construction investment.

The Non-Traditional Apprenticeship Incentive Program provides employers with an incentive payment of $1,000 per non-trade apprentice hired and registered after the completion of the required probationary period. Employers are eligible for up to $5,000 in monetary incentives per calendar year and may collect no more than $1,000 for each unique apprentice. NOTE: Non-traditional apprenticeships are apprenticeships that are registered with the Department of Labor and Training that are outside of the construction trades. The required probationary period is a standard that established as part of the apprenticeship approval process and will vary based on the apprenticeship model.

The program is intended to assist in the growth of jobs in Evanston Illinois, through entrepreneurship, helping residents and local business owners to create jobs by starting and retaining sustainable small businesses.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.